[1]
|
祝文涛, 吴丽娟, 陈晖, 等. 应激性心肌病1例报告[J]. 南昌大学学报, 2020, 60(6): 104-106.
|
[2]
|
赵凯凯, 白俊琴, 张波. 新型P2Y12受体拮抗剂替格瑞洛广谱抗血小板作用机制的研究进展[J]. 中国动脉硬化杂志, 2022, 30(2): 180-184.
|
[3]
|
Grzegorz, C., Marek, K., Tantry, U.S., et al. (2013) High-Dose, But Not Low-Dose, Aspirin Impairs Anticontractile Effect of Ticagrelor following ADP Stimulation in Rat Tail Artery Smooth Muscle Cells. BioMed Research International, 2013, Article ID 928271. https://doi.org/10.1155/2013/928271
|
[4]
|
赵凯凯, 白俊琴, 张 波. 新型P2Y12受体拮机抗制剂的替格瑞洛广谱抗血小板作用机制的研究进展[J]. 中国动脉硬化杂志, 2022, 30(2): 180-184.
|
[5]
|
Frangieh, A.H., Obeid, S., et al. (2016) ECG Criteria to Differentiate Between Takotsubo (Stress) Cardiomyopathy and Myocardial Infarction. Journal of the American Heart Association, 5, e003418.
https://doi.org/10.1161/JAHA.116.003418
|
[6]
|
Uribarri, A., Nunez-Gil, I.J., Conty, D.A., Vedia, O., Al-mendro-Delia, M., Duran Cambra, A., MartinGarcia, A.C., Barrionuevo-Sanchez, M., Martinez-Selles, M., Raposei-ras-Roubin, S., et al. (2019) Short- and Long-Term Prognosis of Patients with Takotsubo Syndrome Based on Different Triggers: Importance of the Physical Nature. Journal of the American Heart Association, 8, e013701. https://doi.org/10.1161/JAHA.119.013701
|
[7]
|
孟庆勇, 王美荣. 左前分支传导阻滞30例初步分析[J]. 临床合理用药杂志, 2016(9): 163-164.
|
[8]
|
Templin, C., Ghadri, J.R., Diekmann, J., Napp, L.C., Bataiosu, D.R., Jaguszewski, M., Cammann, V.L., Sarcon, A., Geyer, V., Neumann, C.A., et al. (2015) Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. The New England Journal of Medicine, 373, 929-938.
|
[9]
|
Santoro, F., Ieva, R., Musaico, F., Ferraretti, A., Triggiani, G., Tarantino, N., Di Biase, M. and Brunetti, N.D. (2014) Lack of Efficacy of Drug Therapy in Preventing Takotsubo Cardiomyopathy Recurrence: A Meta-Analysis. Clinical Cardiology, 37, 434-439. https://doi.org/10.1002/clc.22280
|
[10]
|
Isogai, T., Matsui, H., Tanaka, H., Fushimi, K. and Yasunaga, H. (2016) Early β-Blocker Use and Inhospital Mortality in Patients with Takotsubo Cardiomyopathy. Heart, 102, 1029-1035. https://doi.org/10.1136/heartjnl-2015-308712
|
[11]
|
Singh, K., Carson, K., Usmani, Z., Sawhney, G., Shah, R. and Horowitz, J. (2014) Systematic Review and Meta-Analysis of Incidence and Correlates of Recurrence of Takotsubo Cardiomyopathy. International Journal of Cardiology, 174, 696-701. https://doi.org/10.1016/j.ijcard.2014.04.221
|
[12]
|
Scidea, B.M., Cannon, C.P., Emanuelsson, H., et al. (2011) The Incidence of Bradyarrhythmias and Clinicalbradyarrhythmic Events in Patients with Acute Coronary Syndromes Treated with Ticagrelor or Elopi-Dogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy. Journal of the American College of Cardiology, 57, 1908-1916. https://doi.org/10.1016/j.jacc.2010.11.056
|
[13]
|
Shum, K. and Yu, H.B. (2017) Ticagrelor Causes Slow Arrhyth-mias or Ventricular Arrest: The Progress of the Study of Slow Arrhythmia or Ventricular Arrest Caused by Ticagrelor. West China Medical Journal, 32, 1602-1605.
|
[14]
|
Ben, S.C., Slim, R., Fathallah, N., et al. (2017) Drug-Induced Hyperuricaemia and Gout. Rheumatology (Oxford), 56, 679-688.
|